Jay Jackson, manager with Avalere Health, discusses the 21st Century Cures Act, which recently passed both houses of Congress by overwhelming majorities. The measure has long been championed by supporters as a vehicle for speeding up approval of new drugs and maintaining U.S. leadership in research. Critics say the bill does too much for big pharma and not enough for patients seeking relief from rising drug prices.

Previous articleLilly and AstraZeneca Expand AD Partnership as Lilly Details Failed Solanezumab Study
Next articleEx-CEO among Six Former Insys Executives Arrested on Subsys Racketeering Charges